Although Tenet’s financial statement close process is not yet fully completed, the company currently estimates that its Adjusted EBITDA for the year ended December 31, 2025, will be at the upper end of its current Adjusted EBITDA guidance range of $4.47B-$4.57B. The results were driven, among other things, by strong same store revenue growth and disciplined expense management.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on THC:
- Wells says ‘Great Healthcare Plan’ lacks new onerous proposals
- Tenet Healthcare price target lowered to $230 from $233 at TD Cowen
- Tenet Healthcare price target lowered to $229 from $252 at Wells Fargo
- Tenet Healthcare price target raised to $247 from $232 at Morgan Stanley
- Hospital stocks lower after Republicans propose Medicare funding cut